The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 25, 2020

Filed:

Jan. 15, 2019
Applicants:

Intercept Pharmaceuticals, Inc., New York, NY (US);

Sumitomo Dainippon Pharma Co., Ltd., Osaka-shi, Osaka, JP;

Inventors:

Richard Gail Lancaster, San Diego, CA (US);

Kay K. Olmstead, Escondido, CA (US);

Masashi Kagihiro, Suita, JP;

Mitsuhiro Matono, Osaka, JP;

Ikuko Taoka, Toyonaka, JP;

Mark Pruzanski, New York, NY (US);

David Shapiro, Rancho Santa Fe, CA (US);

Roya Hooshmand-Rad, San Diego, CA (US);

Richard Pencek, San Diego, CA (US);

Cathi Sciacca, San Diego, CA (US);

Lise Eliot, San Diego, CA (US);

Jeffrey Edwards, San Diego, CA (US);

Leigh A. MacConell, Encinitas, CA (US);

Tonya K. Marmon, San Diego, CA (US);

Assignee:

Intercept Pharmaceuticals, Inc., New York, NY (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/575 (2006.01); A61K 47/50 (2017.01); A61K 9/16 (2006.01); A61K 9/14 (2006.01); C07J 9/00 (2006.01); A61K 9/20 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/575 (2013.01); A61K 9/14 (2013.01); A61K 9/1617 (2013.01); A61K 9/2054 (2013.01); A61K 9/2059 (2013.01); A61K 9/2072 (2013.01); A61K 45/06 (2013.01); A61K 47/50 (2017.08); C07J 9/005 (2013.01);
Abstract

The disclosure relates to obeticholic acid formulations with improved stability, dissolution, and/or solubility, methods of preparing the same for use and methods of treating various diseases and conditions.


Find Patent Forward Citations

Loading…